{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T05:10:03Z","timestamp":1744607403988,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Jilin Provincial Department of Finance","doi-asserted-by":"crossref","award":["2018SCZWSZX-052"],"award-info":[{"award-number":["2018SCZWSZX-052"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95100-z","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T04:28:16Z","timestamp":1744604896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating citrate as a mediator in the relationship between HMGCR inhibitors and chronic hepatitis B: a Mendelian randomization study"],"prefix":"10.1038","volume":"15","author":[{"given":"Lili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"95100_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu, Y. C., Huang, D. Q. & Nguyen, M. H. Global burden of hepatitis B virus: Current status, missed opportunities and a call for action. Nat. Rev. Gastroenterol. Hepatol. 20, 524\u2013537. https:\/\/doi.org\/10.1038\/s41575-023-00760-9 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"95100_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12072-021-10137-2","volume":"15","author":"A Koffas","year":"2021","unstructured":"Koffas, A. et al. Chronic hepatitis B: The demise of the \u2018inactive carrier\u2019 phase. Hepatol. Int. 15, 290\u2013300. https:\/\/doi.org\/10.1007\/s12072-021-10137-2 (2021).","journal-title":"Hepatol. Int."},{"key":"95100_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cld.2022.08.001","volume":"27","author":"A Robinson","year":"2023","unstructured":"Robinson, A., Wong, R. & Gish, R. G. Chronic hepatitis B virus and hepatitis D virus: New developments. Clin. Liver Dis. 27, 17\u201325. https:\/\/doi.org\/10.1016\/j.cld.2022.08.001 (2023).","journal-title":"Clin. Liver Dis."},{"key":"95100_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/v12090998","author":"GS Duraisamy","year":"2020","unstructured":"Duraisamy, G. S. et al. Advanced therapeutics, vaccinations, and precision medicine in the treatment and management of chronic hepatitis B viral infections; Where are we and where are we going?. Viruses https:\/\/doi.org\/10.3390\/v12090998 (2020).","journal-title":"Viruses"},{"key":"95100_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/07853890.2021.1956686","volume":"53","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi, A. et al. Statin therapy in chronic viral hepatitis: A systematic review and meta-analysis of nine studies with 195,602 participants. Ann. Med. 53, 1227\u20131242. https:\/\/doi.org\/10.1080\/07853890.2021.1956686 (2021).","journal-title":"Ann. Med."},{"key":"95100_CR6","doi-asserted-by":"publisher","first-page":"5389044","DOI":"10.1155\/2022\/5389044","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. A meta-analysis of statin use and risk of hepatocellular carcinoma. Can. J. Gastroenterol. Hepatol. 2022, 5389044. https:\/\/doi.org\/10.1155\/2022\/5389044 (2022).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"95100_CR7","doi-asserted-by":"publisher","first-page":"3443813","DOI":"10.1155\/2022\/3443813","volume":"2022","author":"M Gharehbeglou","year":"2022","unstructured":"Gharehbeglou, M., Yazdani, S., White, K., Haeri, M. R. & Masoumzadeh, N. Atorvastatin rapidly reduces hepatitis B Viral load in combination with tenofovir: A prospective clinical trial. Can. J. Infect. Dis. Med. Microbiol. 2022, 3443813. https:\/\/doi.org\/10.1155\/2022\/3443813 (2022).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"95100_CR8","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.3748\/wjg.v22.i27.6201","volume":"22","author":"M Janicko","year":"2016","unstructured":"Janicko, M., Drazilova, S., Pella, D., Fedacko, J. & Jarcuska, P. Pleiotropic effects of statins in the diseases of the liver. World J. Gastroenterol. 22, 6201\u20136213. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6201 (2016).","journal-title":"World J. Gastroenterol."},{"key":"95100_CR9","doi-asserted-by":"publisher","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Metabolomics in viral hepatitis: Advances and review. Front. Cell. Infect. Microbiol. 13, 1189417. https:\/\/doi.org\/10.3389\/fcimb.2023.1189417 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"95100_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-016-0318-8","volume":"8","author":"JC Schoeman","year":"2016","unstructured":"Schoeman, J. C. et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Med. 8, 64. https:\/\/doi.org\/10.1186\/s13073-016-0318-8 (2016).","journal-title":"Genome Med."},{"key":"95100_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11306-020-01767-y","volume":"17","author":"HTT Nguyen","year":"2021","unstructured":"Nguyen, H. T. T., Wimmer, R., Le, V. Q. & Krarup, H. B. Metabolic fingerprint of progression of chronic hepatitis B: Changes in the metabolome and novel diagnostic possibilities. Metabolomics 17, 16. https:\/\/doi.org\/10.1007\/s11306-020-01767-y (2021).","journal-title":"Metabolomics"},{"key":"95100_CR12","doi-asserted-by":"publisher","first-page":"636897","DOI":"10.3389\/fmicb.2021.636897","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Multifaceted interaction between hepatitis B virus infection and lipid metabolism in hepatocytes: A potential target of antiviral therapy for chronic hepatitis B. Front. Microbiol. 12, 636897. https:\/\/doi.org\/10.3389\/fmicb.2021.636897 (2021).","journal-title":"Front. Microbiol."},{"key":"95100_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12080753","author":"L Fernandes Silva","year":"2022","unstructured":"Fernandes Silva, L., Ravi, R., Vangipurapu, J. & Laakso, M. Metabolite signature of simvastatin treatment involves multiple metabolic pathways. Metabolites https:\/\/doi.org\/10.3390\/metabo12080753 (2022).","journal-title":"Metabolites"},{"key":"95100_CR14","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","journal-title":"BMJ"},{"key":"95100_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009238","author":"R Schwartz","year":"2021","unstructured":"Schwartz, R., Gagliano Taliun, S. A. & Evans, D. M. Ten simple rules for conducting a Mendelian randomization study. PLOS Comput. Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1009238 (2021).","journal-title":"PLOS Comput. Biol."},{"key":"95100_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ https:\/\/doi.org\/10.1136\/bmj.n2233 (2021).","journal-title":"BMJ"},{"key":"95100_CR17","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z (2021).","journal-title":"Nat. Genet."},{"key":"95100_CR18","doi-asserted-by":"publisher","first-page":"7092414","DOI":"10.1155\/2018\/7092414","volume":"2018","author":"X Liang","year":"2018","unstructured":"Liang, X., He, Q. & Zhao, Q. Effect of stains on LDL reduction and liver safety: A systematic review and meta-analysis. Biomed. Res. Int. 2018, 7092414. https:\/\/doi.org\/10.1155\/2018\/7092414 (2018).","journal-title":"Biomed. Res. Int."},{"key":"95100_CR19","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M. & Triantos, C. NAFLD and HBV interplay\u2014related mechanisms underlying liver disease progression. Front. Immunol. 13, 965548. https:\/\/doi.org\/10.3389\/fimmu.2022.965548 (2022).","journal-title":"Front. Immunol."},{"key":"95100_CR20","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3748\/wjg.v19.i14.2262","volume":"19","author":"YJ Li","year":"2013","unstructured":"Li, Y. J., Zhu, P., Liang, Y., Yin, W. G. & Xiao, J. H. Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells. World J. Gastroenterol. 19, 2262\u20132269. https:\/\/doi.org\/10.3748\/wjg.v19.i14.2262 (2013).","journal-title":"World J. Gastroenterol."},{"key":"95100_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2020.08.002","volume":"73","author":"AR Afshari","year":"2021","unstructured":"Afshari, A. R., Mollazadeh, H., Henney, N. C., Jamialahmad, T. & Sahebkar, A. Effects of statins on brain tumors: A review. Semin. Cancer Biol. 73, 116\u2013133. https:\/\/doi.org\/10.1016\/j.semcancer.2020.08.002 (2021).","journal-title":"Semin. Cancer Biol."},{"key":"95100_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/hco.0000000000000397","volume":"32","author":"V Bianconi","year":"2017","unstructured":"Bianconi, V., Sahebkar, A., Banach, M. & Pirro, M. Statins, haemostatic factors and thrombotic risk. Curr. Opin. Cardiol. 32, 460\u2013466. https:\/\/doi.org\/10.1097\/hco.0000000000000397 (2017).","journal-title":"Curr. Opin. Cardiol."},{"key":"95100_CR23","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1097\/hep.0000000000000278","volume":"78","author":"SR Sharpton","year":"2023","unstructured":"Sharpton, S. R. & Loomba, R. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology 78, 1896\u20131906. https:\/\/doi.org\/10.1097\/hep.0000000000000278 (2023).","journal-title":"Hepatology"},{"key":"95100_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.repc.2015.09.006","volume":"35","author":"S Costa","year":"2016","unstructured":"Costa, S., Reina-Couto, M., Albino-Teixeira, A. & Sousa, T. Statins and oxidative stress in chronic heart failure. Rev. Port. Cardiol. 35, 41\u201357. https:\/\/doi.org\/10.1016\/j.repc.2015.09.006 (2016).","journal-title":"Rev. Port. Cardiol."},{"key":"95100_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12035-014-9030-0","volume":"53","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Atorvastatin protects NSC-34 motor neurons against oxidative stress by activating PI3K, ERK and free radical scavenging. Mol. Neurobiol. 53, 695\u2013705. https:\/\/doi.org\/10.1007\/s12035-014-9030-0 (2016).","journal-title":"Mol. Neurobiol."},{"key":"95100_CR26","doi-asserted-by":"publisher","first-page":"G407","DOI":"10.1152\/ajpgi.00441.2016","volume":"312","author":"R Schierwagen","year":"2017","unstructured":"Schierwagen, R., Uschner, F. E., Magdaleno, F., Klein, S. & Trebicka, J. Rationale for the use of statins in liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G407-g412. https:\/\/doi.org\/10.1152\/ajpgi.00441.2016 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"95100_CR27","doi-asserted-by":"publisher","first-page":"18175","DOI":"10.1038\/srep18175","volume":"5","author":"R Gao","year":"2015","unstructured":"Gao, R. et al. Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma. Sci. Rep. 5, 18175. https:\/\/doi.org\/10.1038\/srep18175 (2015).","journal-title":"Sci. Rep."},{"key":"95100_CR28","doi-asserted-by":"publisher","first-page":"14949","DOI":"10.18632\/aging.103554","volume":"12","author":"FF Cai","year":"2020","unstructured":"Cai, F. F. et al. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma. Aging 12, 14949\u201314965. https:\/\/doi.org\/10.18632\/aging.103554 (2020).","journal-title":"Aging"},{"key":"95100_CR29","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/pmic.200700849","volume":"8","author":"A Tong","year":"2008","unstructured":"Tong, A. et al. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Proteomics 8, 2012\u20132023. https:\/\/doi.org\/10.1002\/pmic.200700849 (2008).","journal-title":"Proteomics"},{"key":"95100_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jmv.20427","volume":"77","author":"M Hajjou","year":"2005","unstructured":"Hajjou, M. et al. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J. Med. Virol. 77, 57\u201365. https:\/\/doi.org\/10.1002\/jmv.20427 (2005).","journal-title":"J. Med. Virol."},{"key":"95100_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhep.2007.06.021","volume":"48","author":"F Yang","year":"2008","unstructured":"Yang, F. et al. Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J. Hepatol. 48, 12\u201319. https:\/\/doi.org\/10.1016\/j.jhep.2007.06.021 (2008).","journal-title":"J. Hepatol."},{"key":"95100_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/v15122359","author":"Y Li","year":"2023","unstructured":"Li, Y. & Ou, J. J. Regulation of mitochondrial metabolism by hepatitis B virus. Viruses https:\/\/doi.org\/10.3390\/v15122359 (2023).","journal-title":"Viruses"},{"key":"95100_CR33","doi-asserted-by":"publisher","first-page":"e0058023","DOI":"10.1128\/jvi.00580-23","volume":"97","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Mitochondrial glycerol-3-phosphate dehydrogenase restricts HBV replication via the TRIM28-mediated degradation of HBx. J. Virol. 97, e0058023. https:\/\/doi.org\/10.1128\/jvi.00580-23 (2023).","journal-title":"J. Virol."},{"key":"95100_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713332","author":"W Amjad","year":"2023","unstructured":"Amjad, W. et al. Circulating citrate is associated with liver fibrosis in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241713332 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"95100_CR35","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3748\/wjg.v27.i26.3971","volume":"27","author":"YW Shi","year":"2021","unstructured":"Shi, Y. W., Yang, R. X. & Fan, J. G. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. World J. Gastroenterol. 27, 3971\u20133983. https:\/\/doi.org\/10.3748\/wjg.v27.i26.3971 (2021).","journal-title":"World J. Gastroenterol."},{"key":"95100_CR36","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1073\/pnas.78.5.2861","volume":"78","author":"E Van Schaftingen","year":"1981","unstructured":"Van Schaftingen, E. & Hers, H. G. Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-biphosphate. Proc. Natl. Acad. Sci. U. S. A. 78, 2861\u20132863. https:\/\/doi.org\/10.1073\/pnas.78.5.2861 (1981).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"95100_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126587","author":"P Icard","year":"2021","unstructured":"Icard, P. et al. Understanding the central role of citrate in the metabolism of cancer cells and tumors: An update. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22126587 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"95100_CR38","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.Can-17-2959","volume":"78","author":"ME Mycielska","year":"2018","unstructured":"Mycielska, M. E. et al. Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in vivo. Cancer Res. 78, 2513\u20132523. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2959 (2018).","journal-title":"Cancer Res."},{"key":"95100_CR39","doi-asserted-by":"publisher","first-page":"e2101553","DOI":"10.1002\/advs.202101553","volume":"9","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Citrate promotes excessive lipid biosynthesis and senescence in tumor cells for tumor therapy. Adv. Sci. 9, e2101553. https:\/\/doi.org\/10.1002\/advs.202101553 (2022).","journal-title":"Adv. Sci."},{"key":"95100_CR40","doi-asserted-by":"publisher","first-page":"188987","DOI":"10.1016\/j.bbcan.2023.188987","volume":"1878","author":"P Icard","year":"2023","unstructured":"Icard, P., Simula, L., Zahn, G., Alifano, M. & Mycielska, M. E. The dual role of citrate in cancer. Biochim. Biophys. Acta Rev. Cancer 1878, 188987. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188987 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"95100_CR41","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.febslet.2013.06.019","volume":"587","author":"B van de Wier","year":"2013","unstructured":"van de Wier, B. et al. Elevated citrate levels in non-alcoholic fatty liver disease: The potential of citrate to promote radical production. FEBS Lett. 587, 2461\u20132466. https:\/\/doi.org\/10.1016\/j.febslet.2013.06.019 (2013).","journal-title":"FEBS Lett."},{"key":"95100_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/imm.12659","volume":"149","author":"P Convertini","year":"2016","unstructured":"Convertini, P. et al. The contribution of the citrate pathway to oxidative stress in down syndrome. Immunology 149, 423\u2013431. https:\/\/doi.org\/10.1111\/imm.12659 (2016).","journal-title":"Immunology"},{"key":"95100_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","volume":"9","author":"NC Williams","year":"2018","unstructured":"Williams, N. C. & O\u2019Neill, L. A. J. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141. https:\/\/doi.org\/10.3389\/fimmu.2018.00141 (2018).","journal-title":"Front. Immunol."},{"key":"95100_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020141","author":"R Mosaoa","year":"2021","unstructured":"Mosaoa, R., Kasprzyk-Pawelec, A., Fernandez, H. R. & Avantaggiati, M. L. The mitochondrial citrate carrier SLC25A1\/CIC and the fundamental role of citrate in cancer. Inflamm. Beyond. Biomol. https:\/\/doi.org\/10.3390\/biom11020141 (2021).","journal-title":"Inflamm. Beyond. Biomol."},{"key":"95100_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1515\/hsz-2013-0271","volume":"395","author":"V Iacobazzi","year":"2014","unstructured":"Iacobazzi, V. & Infantino, V. Citrate\u2014new functions for an old metabolite. Biol. Chem. 395, 387\u2013399. https:\/\/doi.org\/10.1515\/hsz-2013-0271 (2014).","journal-title":"Biol. Chem."},{"key":"95100_CR46","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.2174\/0929867325666180510124558","volume":"26","author":"V Infantino","year":"2019","unstructured":"Infantino, V., Pierri, C. L. & Iacobazzi, V. Metabolic routes in inflammation: The citrate pathway and its potential as therapeutic target. Curr. Med. Chem. 26, 7104\u20137116. https:\/\/doi.org\/10.2174\/0929867325666180510124558 (2019).","journal-title":"Curr. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95100-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T04:28:17Z","timestamp":1744604897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95100-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95100"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95100-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12768"}}